NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$10.64
Tradestie Score
58
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+41.5%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$59.77
|
$2.24B | - | 54 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.79
|
$2.22B | - | 61 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$84.62
|
$1.77B | - | 64 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$17.70
|
$1.56B | - | 56 | Compare |
|
NEOG
Neogen Corp
|
$9.39
|
$1.26B | - | 59 | Compare |
|
OPK
Opko Health Inc.
|
$1.41
|
$1.23B | - | 58 | Compare |
|
CDNA
CareDx, Inc.
|
$24.05
|
$798.40M | - | 62 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.05
|
$719.31M | - | 45 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$20.65
|
$667.77M | - | 64 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$10.03
|
$612.76M | - | 56 | Compare |
More NEO Analysis
Data updated: Jun 16, 2026 | Industry: Diagnostics & Research (SIC 8734)
35 stocks in this industry